| Identification |
| Name: | 3-Oxazolidinepropanoicacid, a-hydroxy-5,5-dimethyl-2,4-dioxo-b-phenyl-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester, (aR,bS)- |
| Synonyms: | 3-Oxazolidinepropanoicacid, a-hydroxy-5,5-dimethyl-2,4-dioxo-b-phenyl-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester, [2aR-[2aa,4b,4ab,6b,9a(aR*,bS*),11a,12a,12aa,12ba]]-;7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.;RPR 104943 |
| CAS: | 157067-34-0 |
| Molecular Formula: | C43H49 N O15 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C43H49NO15/c1-21-25(56-36(51)31(48)29(23-14-10-8-11-15-23)44-37(52)40(5,6)59-38(44)53)19-43(54)34(57-35(50)24-16-12-9-13-17-24)32-41(7,33(49)30(47)28(21)39(43,3)4)26(46)18-27-42(32,20-55-27)58-22(2)45/h8-17,25-27,29-32,34,46-48,54H,18-20H2,1-7H3/t25-,26-,27+,29-,30+,31+,32?,34-,41+,42-,43+/m0/s1 |
| Molecular Structure: |
 |
| Properties |
| Refractive index: | 1.644 |
| Usage: | The major human metabolite 4 (M4) of Docetaxel |
| Safety Data |
| |
 |
